P&F Receives FDA Green Light for Clinical Trial Targeting Severe Tricuspid Regurgitation P&F USA has secured FDA approval for the TRICAV II clinical trial. This pivotal trial aims to evaluate a treatment for patients with severe tricuspid regurgitation.

P&F Receives FDA Green Light for Clinical Trial Targeting Severe Tricuspid Regurgitation #United_States #FDA_Approval #Wilmington #TricValve #PF_Products